Molecular exploitation of apoptosis pathways in prostate cancer:
This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens wi...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London
Imperial College Press
c2012
|
| Schriftenreihe: | Molecular medicine and medicinal chemistry
v. 5 |
| Schlagworte: | |
| Online-Zugang: | FHN01 URL des Erstveroeffentlichers |
| Zusammenfassung: | This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials |
| Beschreibung: | xi, 217 p. col. ill |
| ISBN: | 9781848164505 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044633433 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 171120s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 9781848164505 |c electronic bk. |9 978-1-84816-450-5 | ||
| 024 | 7 | |a 10.1142/P667 |2 doi | |
| 035 | |a (ZDB-124-WOP)00002660 | ||
| 035 | |a (OCoLC)1012713175 | ||
| 035 | |a (DE-599)BVBBV044633433 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-92 | ||
| 082 | 0 | |a 616.99463 |2 22 | |
| 084 | |a XH 8017 |0 (DE-625)152949:13146 |2 rvk | ||
| 100 | 1 | |a Kyprianou, Natasha |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Molecular exploitation of apoptosis pathways in prostate cancer |c Natasha Kyprianou |
| 264 | 1 | |a London |b Imperial College Press |c c2012 | |
| 300 | |a xi, 217 p. |b col. ill | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Molecular medicine and medicinal chemistry |v v. 5 | |
| 520 | |a This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials | ||
| 650 | 4 | |a Prostate / Cancer / Treatment | |
| 650 | 4 | |a Apoptosis | |
| 650 | 0 | 7 | |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Apoptosis |0 (DE-588)4291096-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Prostatakrebs |0 (DE-588)4047511-6 |D s |
| 689 | 0 | 1 | |a Apoptosis |0 (DE-588)4291096-1 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 1848164491 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781848164499 |
| 856 | 4 | 0 | |u http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc |x Verlag |z URL des Erstveroeffentlichers |3 Volltext |
| 912 | |a ZDB-124-WOP | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030031405 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc |l FHN01 |p ZDB-124-WOP |q FHN_PDA_WOP |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178043989655552 |
|---|---|
| any_adam_object | |
| author | Kyprianou, Natasha |
| author_facet | Kyprianou, Natasha |
| author_role | aut |
| author_sort | Kyprianou, Natasha |
| author_variant | n k nk |
| building | Verbundindex |
| bvnumber | BV044633433 |
| classification_rvk | XH 8017 |
| collection | ZDB-124-WOP |
| ctrlnum | (ZDB-124-WOP)00002660 (OCoLC)1012713175 (DE-599)BVBBV044633433 |
| dewey-full | 616.99463 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99463 |
| dewey-search | 616.99463 |
| dewey-sort | 3616.99463 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02474nmm a2200481zcb4500</leader><controlfield tag="001">BV044633433</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">171120s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781848164505</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84816-450-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1142/P667</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-124-WOP)00002660</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1012713175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044633433</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99463</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8017</subfield><subfield code="0">(DE-625)152949:13146</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kyprianou, Natasha</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular exploitation of apoptosis pathways in prostate cancer</subfield><subfield code="c">Natasha Kyprianou</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Imperial College Press</subfield><subfield code="c">c2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xi, 217 p.</subfield><subfield code="b">col. ill</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Molecular medicine and medicinal chemistry</subfield><subfield code="v">v. 5</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate / Cancer / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Apoptosis</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Apoptosis</subfield><subfield code="0">(DE-588)4291096-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Apoptosis</subfield><subfield code="0">(DE-588)4291096-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">1848164491</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781848164499</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveroeffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-124-WOP</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030031405</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-124-WOP</subfield><subfield code="q">FHN_PDA_WOP</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044633433 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:57:42Z |
| institution | BVB |
| isbn | 9781848164505 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030031405 |
| oclc_num | 1012713175 |
| open_access_boolean | |
| owner | DE-92 |
| owner_facet | DE-92 |
| physical | xi, 217 p. col. ill |
| psigel | ZDB-124-WOP ZDB-124-WOP FHN_PDA_WOP |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Imperial College Press |
| record_format | marc |
| series2 | Molecular medicine and medicinal chemistry |
| spelling | Kyprianou, Natasha Verfasser aut Molecular exploitation of apoptosis pathways in prostate cancer Natasha Kyprianou London Imperial College Press c2012 xi, 217 p. col. ill txt rdacontent c rdamedia cr rdacarrier Molecular medicine and medicinal chemistry v. 5 This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials Prostate / Cancer / Treatment Apoptosis Prostatakrebs (DE-588)4047511-6 gnd rswk-swf Apoptosis (DE-588)4291096-1 gnd rswk-swf Prostatakrebs (DE-588)4047511-6 s Apoptosis (DE-588)4291096-1 s 1\p DE-604 Erscheint auch als Druck-Ausgabe 1848164491 Erscheint auch als Druck-Ausgabe 9781848164499 http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc Verlag URL des Erstveroeffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Kyprianou, Natasha Molecular exploitation of apoptosis pathways in prostate cancer Prostate / Cancer / Treatment Apoptosis Prostatakrebs (DE-588)4047511-6 gnd Apoptosis (DE-588)4291096-1 gnd |
| subject_GND | (DE-588)4047511-6 (DE-588)4291096-1 |
| title | Molecular exploitation of apoptosis pathways in prostate cancer |
| title_auth | Molecular exploitation of apoptosis pathways in prostate cancer |
| title_exact_search | Molecular exploitation of apoptosis pathways in prostate cancer |
| title_full | Molecular exploitation of apoptosis pathways in prostate cancer Natasha Kyprianou |
| title_fullStr | Molecular exploitation of apoptosis pathways in prostate cancer Natasha Kyprianou |
| title_full_unstemmed | Molecular exploitation of apoptosis pathways in prostate cancer Natasha Kyprianou |
| title_short | Molecular exploitation of apoptosis pathways in prostate cancer |
| title_sort | molecular exploitation of apoptosis pathways in prostate cancer |
| topic | Prostate / Cancer / Treatment Apoptosis Prostatakrebs (DE-588)4047511-6 gnd Apoptosis (DE-588)4291096-1 gnd |
| topic_facet | Prostate / Cancer / Treatment Apoptosis Prostatakrebs |
| url | http://www.worldscientific.com/worldscibooks/10.1142/P667#t=toc |
| work_keys_str_mv | AT kyprianounatasha molecularexploitationofapoptosispathwaysinprostatecancer |